The Impact of Median Model for End-Stage Liver Disease at Transplant Minus 3 National Policy on Waitlist Outcomes in Patients With and Without Hepatocellular Carcinoma.

Author List
Bernards S, Hirose R, Yao FY, Jin C, Dodge JL, Huang CY, Mehta N
Publication ID (Profile URL)
https://researcherprofiles.org/profile/242616645
Publication Year
2021
PubMed ID
34761847
Publication Title
Bernards S, Hirose R, Yao FY, Jin C, Dodge JL, Huang CY, Mehta N. The Impact of Median Model for End-Stage Liver Disease at Transplant Minus 3 National Policy on Waitlist Outcomes in Patients With and Without Hepatocellular Carcinoma. Liver Transpl. 2022 03; 28(3):376-385.